What You Should Know:
Deloitte has published some new research about how government can advance biomedical innovation and improve public health.The report shares insights from various government leaders and biomedical industry experts on lessons learned from the COVID-19 pandemic, what’s driving innovation, the challenges and opportunities in partnerships, and the government’s role in sustaining the biomedical industry.
Understanding How the Government Can Catalyze Biomedical
Read More
Biomedical Data
Startup Velsera Launches to Advance Precision Health Through Data-Driven Solutions
What You Should Know:
- New company Velsera was announced at the J.P. Morgan Healthcare Conference supported by thematic-focused impact fund Summa Equity (“Summa”).
- Velsera sets out to amplify the impact of clinicians, researchers and scientists for the benefit of patients around the world. Velsera creates a software platform out of science, technology, and informatics, making data actionable, accelerating the pace and potential of multi-omics.
- Velsera, headquartered in
Read More
Geneial Receives $2.3M NIH Grant for Decentralized Biomedical Data Platform
What You Should Know:
- Digital health company Geneial announces a $2.3M grant from the National Human Genome Research Institute to fund the development of their secure, decentralized platform.
- Geneial will use $2.3M NIH award to build private, decentralized data platform facilitating research of genetic diseases. Geneial's platform will connect researchers of rare genetic diseases with relevant data while preserving patient privacy. Geneial's platform aims to help researchers leverage
Read More
Flywheel Acquires Radiologics, Raises $22M for Biomedical Research Platform
What You Should Know:
- Flywheel, a biomedical research data management platform, announced the acquisition of St. Louis-based Radiologics. The two organizations’ combined capabilities in imaging research data management and analytics provide the medical research community unrivaled end-to-end research workflow solutions—from open source to global enterprise.
- In addition, the company announced a $22M Series C funding round led by 8VC with participation from investors iSelect, Argonautic
Read More
How AI is Enabling Next-Generation Insights from Biomedical Data
COVID-19 caught the world off-guard, sending governments, populations, and the entire healthcare community — physicians, nurses, scientists, pharmaceutical companies, and medical device manufacturers included — scrambling to discover and deliver rapid solutions as millions of lives hanging in the balance.
The heroic efforts of everyone involved have at last brought the end into view; now, as we begin to emerge from the pandemic and are able to assess its long-term impact, one important
Read More
NVIDIA Develops AI Model to Accurately Predict Oxygen Needs for COVID-19 Patients
What You Should Know:
- NVIDIA and Massachusetts General Brigham Hospital
researchers develop an AI model that determines whether a person showing up in
the emergency room with COVID-19 symptoms will need supplemental oxygen hours
or even days after an initial exam.
- The ultimate goal of this model is to predict the
likelihood that a person showing up in the emergency room will need
supplemental oxygen, which can aid physicians in determining the appropriate
level of care for patients,
Read More
Q/A: Life Image CEO Matthew Michela Talks Data Sharing Challenges in Breast Imaging
- President and CEO Matthew Michela talk about how Life Image is creating easier access to breast imaging data while also solving some of data sharing’s biggest snags.
Interoperability—it’s the long-awaited result that evolving HIT promised
to bring with it, and yet, it still gets left behind. Disparate data is not a
problem exclusive to one data type or innovation; breast imaging, for example,
has created some of the toughest challenges. However, there is now an app for
that.
Life Image,
Read More
Can Artifical Intelligence Solve The Chronic Kidney Disease Epidemic?
Chronic kidney disease (CKD) is a growing epidemic worldwide. Currently, there are 850 million individuals suffering from CKD globally, with 40 million in the United States alone. Of these individuals, 96 percent are not aware of having CKD, as kidney disease often exhibits no symptoms until it has progressed to a late stage.
As this epidemic continues to grow, healthcare providers and organizations are working to determine how artificial intelligence (AI) can be used to analyze electronic
Read More
Mount Sinai Appoints Andrew Kasarskis As First-Ever Chief Data Officer
Mount Sinai has appointed Andrew Kasarskis, Ph.D., an internationally recognized expert in biomedical data as the health system’s first-ever Executive Vice President and Chief Data Officer (CDO). In this new role, Dr. Kasarskis will facilitate the accessibility and sharing of clinical, financial, and administrative data, and open application development, all in support of better patient care, decision-making, and healthcare innovation.
Accelerating Data-Driven Discovery and Patient
Read More
Click Therapeutics Lands $17M to Advance Prescription Digital Therapeutics Platform
Click Therapeutics, Inc. (“Click”), a provider of Digital Therapeutics solutions as prescription medical treatments, has raised $17 million in funding led by Sanofi Ventures, the corporate venture capital arm of Sanofi. Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. Among these areas are rare diseases, vaccines, potential cures in other core areas of Sanofi’s
Read More
